vs
Assertio Holdings, Inc.（ASRT）与Farmmi, Inc.（FAMI）财务数据对比。点击上方公司名可切换其他公司
Farmmi, Inc.的季度营收约是Assertio Holdings, Inc.的1.2倍（$16.1M vs $13.5M），Farmmi, Inc.同比增速更快（-55.7% vs -57.9%）
Assertio Therapeutics是一家美国专业制药企业，主要聚焦神经病学、疼痛以及中枢神经系统疾病领域的产品销售与推广。公司前身Depomed成立于1995年，总部位于加利福尼亚州纽瓦克，拥有多款获美国FDA批准的产品，目前在纳斯达克上市。
Farmmi, Inc.是一家经营农产品加工与销售业务的跨国企业，核心业务包括香菇、木耳等多种食用真菌的培育与市场推广，产品品类涵盖竹荪、栗蘑、舞茸、猴头菇等多个品种。公司旗下运营Farmmi Jicai线上店铺，推出Forasen、Farmmi Liangpin品牌的食用菌产品，同时对外出口整朵干香菇与切片干香菇。
ASRT vs FAMI — 直观对比
营收规模更大
FAMI
是对方的1.2倍
$13.5M
营收增速更快
FAMI
高出2.2%
-57.9%
损益表 — Q4 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $13.5M | $16.1M |
| 净利润 | — | $-44.0K |
| 毛利率 | — | 5.0% |
| 营业利润率 | -86.7% | -4.1% |
| 净利率 | — | -0.3% |
| 营收同比 | -57.9% | -55.7% |
| 净利润同比 | — | -107.0% |
| 每股收益（稀释后） | $-4.54 | $-0.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASRTFAMI
| Q4 25 | $13.5M | — | ||
| Q3 25 | $49.5M | — | ||
| Q2 25 | $29.2M | — | ||
| Q1 25 | $26.5M | $16.1M | ||
| Q4 24 | $32.2M | — | ||
| Q3 24 | $29.2M | — | ||
| Q2 24 | $31.1M | — | ||
| Q1 24 | $32.4M | $36.4M |
净利润ASRTFAMI
| Q4 25 | — | — | ||
| Q3 25 | $11.4M | — | ||
| Q2 25 | $-16.4M | — | ||
| Q1 25 | $-13.5M | $-44.0K | ||
| Q4 24 | — | — | ||
| Q3 24 | $-2.9M | — | ||
| Q2 24 | $-3.7M | — | ||
| Q1 24 | $-4.5M | $630.5K |
毛利率ASRTFAMI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 5.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.9% |
营业利润率ASRTFAMI
| Q4 25 | -86.7% | — | ||
| Q3 25 | 23.2% | — | ||
| Q2 25 | -27.5% | — | ||
| Q1 25 | -50.0% | -4.1% | ||
| Q4 24 | -41.9% | — | ||
| Q3 24 | -10.4% | — | ||
| Q2 24 | -11.6% | — | ||
| Q1 24 | -13.4% | 2.5% |
净利率ASRTFAMI
| Q4 25 | — | — | ||
| Q3 25 | 23.1% | — | ||
| Q2 25 | -56.0% | — | ||
| Q1 25 | -51.1% | -0.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -10.0% | — | ||
| Q2 24 | -11.8% | — | ||
| Q1 24 | -13.9% | 1.7% |
每股收益（稀释后）ASRTFAMI
| Q4 25 | $-4.54 | — | ||
| Q3 25 | $0.11 | — | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.14 | $-0.04 | ||
| Q4 24 | $-3.28 | — | ||
| Q3 24 | $-0.03 | — | ||
| Q2 24 | $-0.04 | — | ||
| Q1 24 | $-0.05 | $1.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $94.0M | $166.4M |
| 总资产 | $267.0M | $230.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASRTFAMI
| Q4 25 | $63.4M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $98.2M | — | ||
| Q1 25 | $87.3M | — | ||
| Q4 24 | $100.1M | — | ||
| Q3 24 | $88.6M | — | ||
| Q2 24 | $88.4M | — | ||
| Q1 24 | $80.7M | — |
总债务ASRTFAMI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $38.6M | — |
股东权益ASRTFAMI
| Q4 25 | $94.0M | — | ||
| Q3 25 | $105.8M | — | ||
| Q2 25 | $93.3M | — | ||
| Q1 25 | $108.5M | $166.4M | ||
| Q4 24 | $121.1M | — | ||
| Q3 24 | $130.5M | — | ||
| Q2 24 | $132.2M | — | ||
| Q1 24 | $134.5M | $164.4M |
总资产ASRTFAMI
| Q4 25 | $267.0M | — | ||
| Q3 25 | $319.8M | — | ||
| Q2 25 | $273.8M | — | ||
| Q1 25 | $286.4M | $230.4M | ||
| Q4 24 | $284.7M | — | ||
| Q3 24 | $276.0M | — | ||
| Q2 24 | $279.4M | — | ||
| Q1 24 | $282.0M | $171.9M |
负债/权益比ASRTFAMI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.29× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-30.0M | $14.6M |
| 自由现金流经营现金流 - 资本支出 | — | $14.6M |
| 自由现金流率自由现金流/营收 | — | 90.1% |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASRTFAMI
| Q4 25 | $-30.0M | — | ||
| Q3 25 | $-4.8M | — | ||
| Q2 25 | $19.1M | — | ||
| Q1 25 | $-12.5M | $14.6M | ||
| Q4 24 | $11.5M | — | ||
| Q3 24 | $-35.0K | — | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $7.5M | $-14.9M |
自由现金流ASRTFAMI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $14.6M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ASRTFAMI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 90.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ASRTFAMI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.0% |
现金转化率ASRTFAMI
| Q4 25 | — | — | ||
| Q3 25 | -0.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -23.63× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASRT
| Products | $12.8M | 95% |
| Other | $719.0K | 5% |
FAMI
暂无分部数据
